Susan Kralisch
Leipzig, SN 04103, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
The Impact of Neuregulin 4 on Metabolic Dysregulation in Lipodystrophy.
Journal: Endocrinology
Published: November 15, 2024
Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Patients with Lipodystrophy Syndromes.
Journal: Biomolecules
Published: August 28, 2024
Renal function is a major predictor of circulating acyl-CoA-binding protein/diazepam-binding inhibitor.
Journal: Frontiers in endocrinology
Published: January 27, 2023
Leptin treatment has vasculo-protective effects in lipodystrophic mice.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 26, 2022
Leptin Improves Parameters of Brown Adipose Tissue Thermogenesis in Lipodystrophic Mice.
Journal: Nutrients
Published: June 18, 2021
Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy.
Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy.
Journal: International journal of molecular sciences
Published: August 05, 2020
Pro-neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease.
Journal: European journal of endocrinology
Published: February 01, 2020
The brown fat-secreted adipokine neuregulin 4 is decreased in human and murine chronic kidney disease.
Journal: European journal of endocrinology
Published: January 08, 2019
Leptin decreases circulating inflammatory IL-6 and MCP-1 in mice.
Journal: BioFactors (Oxford, England)
Published: July 09, 2018
Circulating Pro-Neurotensin in gestational diabetes mellitus.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: April 05, 2018
Leptin restores markers of female fertility in lipodystrophy.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 22, 2018
Last Updated: 09/26/2026